Q4 2019 Revance Therapeutics Inc Earnings Call Transcript
Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2019 Financial Results and Corporate Update Conference Call. (Operator Instructions) As a reminder, this call is being recorded today, February 24, 2020.
I would now like to turn the conference call over to Jeanie Herbert, Senior Director of Investor Relations and Corporate Communications for Revance. Please go ahead.
Thank you, Joelle. Joining us on the call today from Revance is President and Chief Executive Officer, Mark Foley; Chief Financial Officer, Toby Schilke; Chief Operating Officer and President of R&D and Product Operations, Dr. Abhay Joshi; Chief Commercial Officer, Aesthetics & Therapeutics, Dustin Sjuts.
Earlier today, Revance released financial results for the fourth quarter and full year ended December 31, 2019. If you have not received this news release or would like to be added to the company's distribution list to receive future releases, please go to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |